THEMISMEDBSETHEMIS MEDICARE LTD.MediumNeutral
Announced Tue, 8 Sept · 22:12 IST

Notice of 56th AGM and Annual Report for FY 2025-26

Board & Shareholder Meetings View source PDFExplain this filing

THEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹132.10
prior close
₹131.75
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+2.0+1.7+0.7-0.1-2.2-9.1-8.4-9.8-6.1
Up moveDown movePending
AI summary

Themis Medicare has sent notice of its 56th AGM on 30th September 2026 along with the Annual Report for FY 2025-26. Consolidated revenue fell to Rs. 342.24 crores from Rs. 405.51 crores in FY25, with EBITDA at Rs. 0.39 crores and PAT at Rs. 1.14 crores. Q4 FY26 showed recovery with revenue up 6.7 percent YoY to Rs. 76.5 crores, EBITDA of Rs. 3.8 crores, and PAT turning positive at Rs. 8.9 crores. AGM agenda includes adopting accounts, declaring dividend, re-appointing Mr. Rajneesh Anand, ratifying Cost Auditor remuneration of Rs. 3 lakhs, and amending Articles of Association.

Likely market impact

Weak full-year results but improving Q4 trends. Dividend declaration and AOA amendment await shareholder approval at AGM.